Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.43 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.42 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 4/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.40 |
| ▸ | FAP | Q12884 | 3/20 | 0.40 |
| ▸ | PREP | P48147 | 1/20 | 0.39 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.39 |
| ▸ | REN | P00797 | 4/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CMA1 | P23946 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL496309 | 0.91 | KLK5 (0.44) | GPR119KLK5SCN9AADORA3ADORA2A | |
| SCHEMBL496315 | 0.83 | KLK5 (0.60) | KLK5ADORA3ADORA2AADORA2BADORA1 | |
| SCHEMBL495892 | 0.76 | DPP4 (0.45) | DPP4KCNH2FAPPREPDPP9 | |
| SCHEMBL495890 | 0.76 | DPP4 (0.45) | DPP4KCNH2FAPPREPDPP9 | |
| SCHEMBL496474 | 0.76 | KLK5 (0.61) | KLK5ADORA3ADORA2AADORA2BADORA1 | |
| SCHEMBL496475 | 0.76 | KLK5 (0.61) | KLK5ADORA3ADORA2AADORA2BADORA1 | |
| Hydrochloric Acid SCHEMBL496003 | 0.75 | DPP4 (0.44) | DPP4KCNH2FAPPREPDPP9 | |
| Hydrochloric Acid SCHEMBL496004 | 0.75 | DPP4 (0.44) | DPP4KCNH2FAPPREPDPP9 | |
| SCHEMBL496196 | 0.75 | SCN9A (0.42) | GPR119KLK5SCN9ADPP4DPP9 | |
| SCHEMBL496197 | 0.75 | SCN9A (0.42) | GPR119KLK5SCN9ADPP4DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1910317-B1 | 1-AMINO LINKED COMPOUNDS | LILLY CO ELI (US) | 2013-07-03 | — | — | EP | disclosed |
| US-8106090-B2 | Antidiabetic agents; prevent of non-insulin dependent diabetes | ELI LILLY AND COMPANY (US) | 2012-01-31 | — | — | US | disclosed |
| US-20080207735-A1 | 1-Amino Linked Compounds | ELI LILLY AND COMPANY | 2008-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080207735-A1 | 1-Amino Linked Compounds | DPP4, DPP3, DPP9 | GPR119 4/4885KLK5 3927/4885SCN9A 467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.